Related Experiment Video
Updated: Jun 21, 2026

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
New insights into the haemostatic function of platelets.
Andrew H Wei1, Simone M Schoenwaelder, Robert K Andrews
1The Australian Centre for Blood Diseases, Monash University, Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia.
Research on platelet function has advanced significantly using mouse models, but clinical diagnosis of bleeding disorders remains challenging. This review focuses on primary platelet disorders and potential mouse model candidates for human conditions.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Platelet haemostatic function is regulated by key molecular events.
- Mouse models with genetically altered platelet proteins have driven research progress.
- Clinical diagnosis of unexplained bleeding disorders lags behind research advancements.
Purpose of the Study:
- To review major primary platelet disorders causing pathological bleeding in humans.
- To highlight lesions identified in mouse models as potential diagnostic candidates.
- To aid physicians in diagnosing atypical or unexplained platelet dysfunction.
Main Methods:
- Literature review of primary platelet disorders.
- Focus on genetic alterations in mouse models of platelet function.
- Correlation of mouse model findings with human platelet dysfunction.
Main Results:
- Advances in understanding platelet molecular events from mouse models.
- Limited clinical progress in diagnosing platelet disorders.
- Identification of potential candidate molecules from mouse studies for human conditions.
Conclusions:
- Mouse models offer valuable insights into platelet biology and dysfunction.
- Bridging the gap between research and clinical diagnosis of platelet disorders is crucial.
- Further investigation of mouse model-derived candidates may improve diagnosis of human platelet dysfunction.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

